Mississippi Administrative Code › Title 30 - Professions and Occupations › Part 3001 - MISSISSIPPI PHARMACY PRACTICE REGULATIONS › Article XI - STOCK CONTAINER LABELING, OUTDATED MERCHANDISE, SANITATION, DISPENSING AND STORAGE REQUIREMENTS

Current through June 25, 2024
1. All drug
			 products which are stored or maintained in a facility permitted by the Board of
			 Pharmacy shall remain in the manufacturer's or repackager's original container.
			 The label of any container in which drugs are maintained must bear the drug
			 name, strength, the manufacturer's control lot number and the expiration date.
Drugs which are precounted and prepackaged, or placed in
				automatic tablet counting machines, for purposes of dispensing shall be
				identifiable as to expiration date and manufacturer's control lot number. The
				containers in which drug products are maintained shall not be labeled in any
				false or misleading manner. The labeling requirements of this ARTICLE are in
				addition to, and not in lieu of, other labeling requirements of the laws of the
				state of Mississippi, rules and regulations of the Mississippi Board of
				Pharmacy, and laws of the United States, or federal regulations.
2. A pharmacist shall not dispense
			 out-of-date drugs and a pharmacy shall not maintain out-of-date drugs
			 intermixed with the stock of current drugs. Out-of-date drugs shall be promptly
			 removed from current stock and stored separately until proper disposal shall be
			 made.
The Board or its representative may seize, embargo,
				quarantine, or place under seal, any prescription drug, controlled substance,
				or medical device which may constitute an imminent danger to the public health
				and safety.
At the conclusion of proceedings, the Board may asses fees
				associated with the storage of, destruction, or disposal of any seized,
				embargoed, or quarantined prescription drugs, controlled substances or medical
				devices
The Board may place under seal all Drugs or Devices that are
				owned by or in the possession, custody, or control of a licensee at the time
				his or her license is Suspended or Revoked or at the time the Board refuses to
				renew his or her license. Drugs or devices so sealed shall not be disposed of
				until appeal rights have expired or disposal is ordered by the Board.
3. Pharmacies shall be maintained
			 in an orderly and sanitary fashion.
4. A pharmacist or a pharmacy shall not
			 accept the return for subsequent resale or exchange any drug after such drug
			 has been taken from the premises where sold, distributed or dispensed and from
			 the control of the pharmacist.
5.
			 All drug products shall be maintained, stored and dispensed in such a manner as
			 to maintain the integrity of the product.
6. Unless requested not to do so, all
			 medication dispensed in a liquid or solid dosage form shall be dispensed in
			 child resistant packaging.
7.
			 Disasters, accidents or emergencies which may affect the strength, purity or
			 labeling of drugs shall be immediately reported to the Board.
8. Customized Patient Medication Packages:
In lieu of dispensing two or more prescribed drug products in
				separate containers, a pharmacist may, with the consent of the patient, a
				patient's care giver, or the prescriber, provide a customized package, known as
				a patient med-pak provided:
A. Patient
			 med-paks shall bear a label (or labels) including all information required on a
			 traditional prescription label. In addition, the med-pak shall bear an
			 identification number unique to that patient med-pak, the date of preparation
			 and the beyond-use date of the patient med-pak (not to exceed ninety(90) days
			 from the date of preparation). If the patient med-pak allows for the removal or
			 separation of individual cells within the med-pak, each cell shall bear a label
			 identifying each of the drug products contained.
B. It is the responsibility of the dispensing
			 pharmacist when preparing the med-pak, to take into account any applicable
			 compendia requirements or guidelines and the physical and chemical
			 compatibility of the dosage forms placed within each cell of the med-pak, as
			 well as any therapeutic incompatibilities that may attend the simultaneous
			 administration of the drugs.
C. In
			 addition to individual prescription filing requirements, a record of each
			 patient med-pak shall be made and filed. Each record shall contain at a
			 minimum:
(1) The name and address of the
			 patient;
(2) The unique
			 identification number of the patient med-pak;
(3) The prescription number for each drug
			 product contained;
(4) The drug
			 name, manufacturer or distributor name and lot number of each drug product
			 contained;
(5) Any special labeling
			 instructions;
(6) Information
			 identifying or describing the design, characteristics, or specifications of the
			 med-pak, sufficient to allow subsequent preparation of the med-pak for the
			 patient;
(7) The date of
			 preparation of the patient med-pak and the beyond-use date that was assigned;
			 and
(8) The name or initials of the
			 pharmacist responsible for preparing the med-pak.